These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26591106)

  • 1. [GLIOBLASTOMA MULTIFORME--THE PROGRESS OF KNOWLEDGE ON THE PATHOGENESIS OF CANCER].
    Wańkowicz P; Nowacki P
    Ann Acad Med Stetin; 2014; 60(2):40-3. PubMed ID: 26591106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological spectrum in recurrences of glioblastoma multiforme.
    Marucci G; Fabbri PV; Morandi L; De Biase D; Di Oto E; Tallini G; Sturiale C; Franceschi E; Frezza GP; Foschini MP
    Pathologica; 2015 Mar; 107(1):1-8. PubMed ID: 26591624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation.
    Kraus JA; Wenghoefer M; Schmidt MC; von Deimling A; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Müller B; Heuser K; Reifenberger G; Schlegel U
    J Neurol; 2000 Jun; 247(6):455-60. PubMed ID: 10929275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme.
    Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q
    J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
    Grunnet ML; O'Neill A; Gilbert M; Hellman R
    Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.
    Raman F; Scribner E; Saut O; Wenger C; Colin T; Fathallah-Shaykh HM
    PLoS One; 2016; 11(1):e0146617. PubMed ID: 26756205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glioblastoma, an example of translational research?].
    Kroonen J; Nguyen-Khac MT; Deprez M; Rogister B; Robe P
    Rev Med Liege; 2008; 63(5-6):251-6. PubMed ID: 18669189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme.
    Lassen U; Sorensen M; Gaziel TB; Hasselbalch B; Poulsen HS
    Anticancer Res; 2013 Apr; 33(4):1657-60. PubMed ID: 23564811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma multiforme.
    Williams DS
    J Insur Med; 2014; 44(1):62-4. PubMed ID: 25004601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
    Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
    Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice.
    Huang P; Allam A; Taghian A; Freeman J; Duffy M; Suit HD
    J Neurosurg; 1995 Aug; 83(2):308-15. PubMed ID: 7616277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
    Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
    Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
    Marton E; Feletti A; Orvieto E; Longatti P
    J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cancer stem cells in glioblastoma.
    Sundar SJ; Hsieh JK; Manjila S; Lathia JD; Sloan A
    Neurosurg Focus; 2014 Dec; 37(6):E6. PubMed ID: 25434391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
    Vymazal J; Wong ET
    Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
    Gao X; Jin W
    Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic features of glioblastoma and their potential impact on survival.
    Nestler U; Lutz K; Pichlmeier U; Stummer W; Franz K; Reulen HJ; Bink A;
    Acta Neurochir (Wien); 2015 Feb; 157(2):179-86. PubMed ID: 25391974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
    Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.